5 Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
42 Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
Trademark Events
Aug 12, 2022
Abandonment Notice E-Mailed - Failure To Respond
Aug 12, 2022
Abandonment Notice Mailed - Failure To Respond
Aug 12, 2022
Abandonment - Failure To Respond Or Late Response
Jan 26, 2022
Notification Of Non-Final Action E-Mailed
Jan 26, 2022
Non-Final Action E-Mailed
Jan 26, 2022
Non-Final Action Written
Jan 10, 2022
Assigned To Examiner
Dec 8, 2021
Automatic Update Of Assignment Of Ownership
Aug 23, 2021
New Application Office Supplied Data Entered In Tram